Chairman Smith on the hearing: “Today, 47 million people in the world live with Alzheimer’s disease and other forms of dementia, and this number is estimated to grow to 131 million by 2050 as populations age.  The total estimated global cost of addressing this condition today is $818 billion, but by as early as next year, it is estimated that this cost will rise to at least one billion.  This hearing is intended to examine the existing and potential options for prevention and treatment of this often devastating disease.”

Witnesses

Panel I

Marie Bernard, M.D.
Deputy Director
National Institute on Aging
National Institutes of Health
[full text of statement]

Roger Glass, M.D.
Director
Fogarty International Center
National Institutes of Health
[full text of statement]

Panel II

Mary Mittelman, Dr.P.H.
Research Professor
Alzheimer’s Disease and Related Dementias Family Support Program
New York University
[full text of statement]
[truth in testimony form]

Richard Mohs, Ph.D.
Chief Scientific Officer
Global Alzheimer’s Platform Foundation
[full text of statement]
[truth in testimony form]

Mr. Michael Splaine
Principal
Splaine Consulting
[full text of statement]
[truth in testimony form]